Definium Therapeutics, Inc.
DFTX NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 6, 2026
ET
EPS Est.
-0.54
EPS Actual
-1.44
Revenue Est.
--
Revenue Actual
--
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
-0.54
Revenue Est.
--
Company Overview
Definium Therapeutics, Inc. (ticker DFTX) is listed on NASDAQ with a market cap of about $5.96B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Time TBD, with consensus EPS of -0.54. In the last 15 reported quarters, EPS beat consensus estimates 4 times.
Actual EPS TrendRecently15Term · Mar 9, 2023 → Aug 6, 2026
Mar 9, 2023Range: -1.44 ~ -0.27Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | -0.54 | Below forecast↓-1.44 | -- | -- |
| May 7, 2026 | -- | -0.47 | Below forecast↓-0.71 | -- | -- |
| Feb 26, 2026 | -- | -0.48 | -0.51 | -- | -- |
| Nov 6, 2025 | -- | -0.52 | Below forecast↓-0.78 | -- | -- |
| Jul 31, 2025 | -- | -0.38 | Below forecast↓-0.50 | -- | -- |
| May 8, 2025 | -- | -0.36 | -0.35 | -- | -- |
| Mar 6, 2025 | -- | -0.33 | Below forecast↓-0.41 | -- | -- |
| Nov 7, 2024 | -- | -0.28 | -0.27 | -- | -- |
| Aug 13, 2024 | -- | -0.30 | Below forecast↓-0.48 | -- | -- |
| May 8, 2024 | -- | -0.66 | Below forecast↓-1.14 | -- | -- |
| Feb 28, 2024 | -- | -0.48 | Below forecast↓-0.59 | -- | $4.8M |
| Nov 2, 2023 | -- | -0.65 | Above forecast↑-0.53 | -- | -- |
| Aug 3, 2023 | -- | -0.54 | Below forecast↓-0.72 | -- | -- |
| May 4, 2023 | -- | -0.41 | Below forecast↓-0.51 | -- | -- |
| Mar 9, 2023 | -- | -0.49 | Above forecast↑-0.27 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-08-06 ↗
Earnings Release8-K · 2026-08-06 ↗
Quarterly10-Q · 2026-05-07 ↗
Earnings Release8-K · 2026-05-07 ↗
Annual10-K · 2026-02-26 ↗
Earnings Release8-K · 2026-02-26 ↗
Quarterly10-Q · 2025-11-06 ↗
Earnings Release8-K · 2025-11-06 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
